Aligos Therapeutics (ALGS) Total Non-Current Liabilities (2019 - 2024)
Aligos Therapeutics (ALGS) reported Total Non-Current Liabilities of $26.74 million for Q3 2024, down 11.2% from the prior quarter.
Powered by 
Analysis
Aligos Therapeutics (ALGS) Total Non-Current Liabilities (2019 - 2024) Analysis & Trends
At the end of FY2023, Aligos Therapeutics posted Total Non-Current Liabilities of $31.85 million.
- Total Non-Current Liabilities has a four-year compound annual growth rate of -37.7% (FY2019 to FY2023).
- By year, Total Non-Current Liabilities came in at $50.51 million in FY2021 (+12.5%), $44.88 million in FY2020 (-78.7%) and $210.95 million in FY2019.
- Five-year quarterly Total Non-Current Liabilities spans a low of $26.14 million in Q1 2024 and a high of $228.23 million in Q3 2020.
- Per Business Quant data, the three quarters before Q3 2024 came in at $30.09 million (Q2 2024), $26.14 million (Q1 2024) and $31.85 million (Q4 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Aligos Therapeutics | 52.47 Mn | -275.94 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 26.74 Mn |
| Jun 30, 2024 | 30.09 Mn |
| Mar 31, 2024 | 26.14 Mn |
| Dec 31, 2023 | 31.85 Mn |
| Sep 30, 2022 | 41.92 Mn |
| Jun 30, 2022 | 45.41 Mn |
| Mar 31, 2022 | 57.45 Mn |
| Dec 31, 2021 | 50.51 Mn |
| Sep 30, 2021 | 45.79 Mn |
| Jun 30, 2021 | 42.73 Mn |
| Mar 31, 2021 | 39.05 Mn |
| Dec 31, 2020 | 44.88 Mn |
| Sep 30, 2020 | 227.94 Mn |
| Dec 31, 2019 | 210.95 Mn |
API Access
Aligos Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ALGS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();